We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+9.23%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$14.9B
AUM Growth
+$734M
(+5.2%)
Cap. Flow
-$271M
Cap. Flow
% of AUM
-1.83%
Top 10 Holdings %
Top 10 Hldgs %
17.52%
Holding
304
New
43
Increased
101
Reduced
105
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$215M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$184M |
| 3 |
Microsoft
MSFT
|
+$163M |
| 4 |
Biogen
BIIB
|
+$147M |
| 5 |
Synchrony
SYF
|
+$124M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$236M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$227M |
| 3 |
AbbVie
ABBV
|
+$169M |
| 4 |
Yum! Brands
YUM
|
+$147M |
| 5 |
Analog Devices
ADI
|
+$129M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.21% |
| 2 | Technology | 15.59% |
| 3 | Consumer Discretionary | 15.51% |
| 4 | Communication Services | 11.55% |
| 5 | Industrials | 11.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
TJX Companies
TJX
$176B
| $99.1M | 0.67% |
2,793,716
+359,400
| +15% | +$12.8M |
|
52
CoStar Group
CSGP
$12.2B
| $97.7M | 0.66% |
4,728,470
-24,740
| -0.5% | -$492K |
|
|
SCHW
53
Charles Schwab
SCHW
$188B
| $96.2M | 0.65% |
2,922,220
-92,161
| -3% | -$2.92M |
|
54
Assurant
AIZ
$14.8B
| $95.8M | 0.65% |
1,189,904
+88,605
| +8% | +$7.31M |
|
55
Ulta Beauty
ULTA
$23.1B
| $94.8M | 0.64% |
512,334
-194,795
| -28% | -$33.7M |
|
56
Align Technology
ALGN
$12.3B
| $94.1M | 0.63% |
1,429,348
+29,971
| +2% | +$1.92M |
|
57
Starbucks
SBUX
$121B
| $91.8M | 0.62% |
1,528,785
-5,512
| -0.4% | -$336K |
|
58
RH
RH
$3.72B
| $86.7M | 0.58% |
1,091,118
+94,712
| +10% | +$8.79M |
|
59
Textron
TXT
$15.2B
| $84.9M | 0.57% |
2,019,902
-104,796
| -5% | -$4.33M |
|
60
United Therapeutics
UTHR
$22B
| $84.8M | 0.57% |
541,235
-489,338
| -47% | -$71.2M |
|
|
IHS
61
DELISTED
IHS INC CL-A COM STK
IHS
| $81.1M | 0.55% |
684,391
+12,774
| +2% | +$1.52M |
|
62
Union Pacific
UNP
$176B
| $81M | 0.55% |
1,036,258
-470,297
| -31% | -$40.3M |
|
63
Icon
ICLR
$12.7B
| $80.8M | 0.54% |
1,040,495
-185,985
| -15% | -$13.3M |
|
64
Nexstar Media Group
NXST
$5.88B
| $80.4M | 0.54% |
1,369,026
+440,943
| +48% | +$24.4M |
|
65
Lam Research
LRCX
$392B
| $79.6M | 0.54% |
10,028,120
-2,047,770
| -17% | -$15.4M |
|
|
MDRX
66
DELISTED
Veradigm Inc. Common Stock
MDRX
| $77.5M | 0.52% |
5,038,619
-765,673
| -13% | -$11M |
|
|
TSS
67
DELISTED
Total System Services, Inc.
TSS
| $77.5M | 0.52% |
1,555,387
-438,442
| -22% | -$22.9M |
|
68
Snap-on
SNA
$21.7B
| $75.5M | 0.51% |
440,202
+48,101
| +12% | +$8.01M |
|
69
Bread Financial
BFH
$4.55B
| $75.1M | 0.51% |
340,128
+20,811
| +7% | +$4.71M |
|
|
RHT
70
DELISTED
Red Hat Inc
RHT
| $72.6M | 0.49% |
876,624
+54,068
| +7% | +$4.29M |
|
|
GRA
71
DELISTED
W.R. Grace & Co.
GRA
| $72.5M | 0.49% |
728,163
+467,908
| +180% | +$45.8M |
|
72
Neurocrine Biosciences
NBIX
$16.6B
| $69.1M | 0.47% |
1,221,642
+75,797
| +7% | +$3.85M |
|
|
SIX
73
DELISTED
Six Flags Entertainment Corp.
SIX
| $68.4M | 0.46% |
1,244,133
+113,490
| +10% | +$5.86M |
|
|
MDVN
74
DELISTED
MEDIVATION, INC.
MDVN
| $67.8M | 0.46% |
1,403,498
+327,652
| +30% | +$14.1M |
|
75
Service Corp International
SCI
$11.6B
| $67.1M | 0.45% |
2,579,099
-375,471
| -13% | -$10.3M |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q4 2015 Portfolio in Review
As of Q4 2015, Westfield Capital Management held 304 positions worth $14.9B, up 5.2% from $14.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Westfield Capital Management's Q4 2015 filing shows 43 new, 101 increased, 105 reduced and 32 closed positions. Its largest new stake was Alphabet (Google) Class A: 5,804,860 shares worth $226M. The largest sale was Vertex Pharmaceuticals, an estimated $236M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
- Westfield Capital Management's largest Q4 2015 buy was Alphabet (Google) Class A: 5,804,860 shares worth $226M.
- Westfield Capital Management added most to Bristol-Myers Squibb in Q4 2015, an estimated $184M increase.
- Westfield Capital Management's biggest Q4 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $236M.
- Westfield Capital Management fully exited Analog Devices in Q4 2015, selling an estimated $129M.
- Westfield Capital Management's ten largest holdings make up 18% of its $14.9B portfolio in Q4 2015.
- Westfield Capital Management opened 43 new positions and closed 32 in Q4 2015.
- Westfield Capital Management's portfolio value rose 5.2% quarter-over-quarter to $14.9B.
Based on Westfield Capital Management's 13F filing for Q4 2015, filed 11 Feb 2016.